Former FDA deputy commissioner Dr. Scott Gottlieb is the rumored choice to head the agency, with the full nomination expected by the end of the day. Like most of the Trump Administration’s other high-office picks, Gottlieb is known for his anti-regulatory stance and is in favor of speeding up the drug-approval process, especially for older generics. Considered more mainstream than earlier choices...
During the month of July, MobiHealthNews reported on 16 digital health companies that raised venture funding. The deals total $149.3 million, which is lower on average when compared to other months this year so far but that's expected for the slower news cycle in the summer.
In the first half of 2016, MobiHealthNews tracked funding for digital health companies that totaled $1.27 billion, as we...
New York City-based Force Therapeutics raised $2.6 million, according to an SEC filing. This brings the company's total funding to date to about $4.8 million.
The company's original investors include former OpenTable CEO Thomas Layton; former CEO of Revolution Health and TicketMaster, John Pleasants; and FiveW Capital Managing Member Randall Winn.
Force Therapeutics has developed a mobile and web...
New York City-based Force Therapeutics raised $1.7 million in a round that the company started September 2013, according to an SEC filing. This brings the company's total funding to date to $2.2 million.
Existing investors include former OpenTable CEO Thomas Layton; former CEO of Revolution Health and TicketMaster, John Pleasants; and FiveW Capital Managing Member Randall Winn. The company raised...
